Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor protein 53 (p53) is a tumor suppressor protein that regulates cell division and prevents cells from proliferating uncontrollably. It plays an essential role in maintaining genomic stability by binding directly to DNA, sensing DNA damage, and deciding cell fate (repair or apoptosis). TP53 is the most frequently mutated gene in human cancers. Mutations are especially common in the core DNA-binding domain and are associated with loss of tumor-suppressive function.
p53 binds specific regulatory regions on target genes, inducing expression of genes that halt cell cycle progression, promote DNA repair mechanisms, or initiate apoptosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor protein 53 (p53).